Blinatumomab Intravenous and Doloracin/L with Lidocaine
Determining the interaction of Blinatumomab Intravenous and Doloracin/L with Lidocaine and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: blinatumomab
Brand name: Blincyto
Synonyms: Blinatumomab
Generic Name: capsaicin / lidocaine / menthol / methyl salicylate topical
Brand name: LidoPro, Terocin, Transderm-iQ
Synonyms: Capsaicin, lidocaine, menthol, and methyl salicylate (topical)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Blinatumomab Intravenous-Dolorex
- Blinatumomab Intravenous-Dolorex Forte
- Blinatumomab Intravenous-Dolotranz
- Blinatumomab Intravenous-Dolutegravir
- Blinatumomab Intravenous-Dolutegravir 10 mg
- Blinatumomab Intravenous-Dolutegravir 25 mg and 50 mg
- Doloracin/L with Lidocaine-Blincyto
- Doloracin/L with Lidocaine-Blisovi 24 Fe
- Doloracin/L with Lidocaine-Blisovi 24 FE birth control
- Doloracin/L with Lidocaine-Blisovi Fe 1.5/30
- Doloracin/L with Lidocaine-Blisovi Fe 1/20
- Doloracin/L with Lidocaine-Blocadren